{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-098047","form_type":"8-K","ticker":"VYGR","cik":"0001640266","company_name":"Voyager Therapeutics, Inc.","filed_at":"2022-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.493768+00:00","generated_at":"2026-06-23T14:15:34.153217+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Voyager Therapeutics appoints new CFO, CSO, and SVP of Corporate Affairs","bullets":["Peter Pfreundschuh named CFO effective Sept 19, 2022; base salary $455K, target bonus 40%, 200K option + 125K RSU.","Todd Carter promoted to CSO effective Sept 19, 2022; base salary $410K, target bonus 40%, 165K option.","Trista Morrison appointed SVP of Corporate Affairs and Chief of Staff to CEO effective Sept 19, 2022.","Julie Burek remains VP of Finance; Pfreundschuh assumes principal financial and accounting officer roles.","Equity grants for Pfreundschuh are inducement awards under Nasdaq Listing Rule 5635(c)(4)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-098047","json":"https://secwatch.observer/filing/0001104659-22-098047.json","markdown":"https://secwatch.observer/filing/0001104659-22-098047.md","text":"https://secwatch.observer/filing/0001104659-22-098047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000110465922098047/0001104659-22-098047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000110465922098047/tm2225311d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T14:15:34.153217+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f20f0a341","claim":"Peter P. Pfreundschuh was appointed as Chief Financial Officer at Voyager Therapeutics, Inc..","evidence_excerpt":"pursuant to which Mr. Pfreundschuh agreed to serve as the Chief Financial Officer of the Company, with the first date of employment to commence on September 19, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465922098047/0001104659-22-098047-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}